Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tocilizumab and Cytokine Release Syndrome (CRS) In Covid-19 Pneumonia: Experience From Single Center of Pakistan

NCT04873141 is registered in ClinicalTrials.gov with Shaheed Zulfiqar Ali Bhutto Medical University as lead sponsor.

NCT NCT04873141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04873141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tocilizumab and Cytokine Release Syndrome (CRS) In Covid-19 Pneumonia: Experience From Single Center of Pakistan
Lead sponsor
Shaheed Zulfiqar Ali Bhutto Medical University
Phase
Observational
Overall status
Completed
Start date
April 28, 2020
Completion date
June 22, 2020
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia, cytokine release syndrome